LGVN Longeveron Inc. - Class A Common stock
$0,82
Preço · Ago 18, 2026
Fundamentais a partir de Ago 12, 2026
Intervalo 52 Semanas
$0–$1
46% of range
Classificação do Analista
BUY
9 analysts
Preço-Alvo
$7
+772% upside
P/E (TTM)
-0.4
ROE
-247.7%
Margem de Lucro Líquido
-1893.6%
LGVN Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.82
Capitalização de Mercado
—
P/E (TTM)
-0.4
EPS (TTM)
$-1.29
Receita (TTM)
$1M
Rendimento div.
—
ROE
-247.7%
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $1
LGVN Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$1M
2020-12-31
→
2025-12-31
EPS
$-1.29
2021-12-31
→
2025-12-31
Fluxo de caixa livre
$-19M
2021-12-31
→
2025-12-31
Margens
-1893.6%
2021-12-31
→
2025-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
LGVN
Mediana de Pares
P/E (TTM)
-0.4
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
LGVN
Mediana de Pares
Gross Margin (Margem Bruta)
67.0%
63.8%
Operating Margin (Margem Operacional)
-1942.2%
—
Net Profit Margin (Margem de Lucro Líquido)
-1893.6%
-198.8%
ROA
-126.8%
-65.0%
ROE
-247.7%
-85.3%
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
LGVN
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
1.3
3.0
Quick Ratio (Índice de Liquidez Seca)
1.2
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
LGVN
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-49.9%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-0.63%
—
Revenue CAGR 5Y (CAGR Receita 5A)
-26.6%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
LGVN
Mediana de Pares
LGVN Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
9 analistas
- Compra forte 2 22,2%
- Compra 5 55,6%
- Manter 2 22,2%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
3 analistas · 2026-08-15
Mediana
$8.00
Média
$7.15
← Abaixo de todos os alvos
$0.82
Mín
$3.00
Máx
$10.45
Alvo mediano
$8.00
+875,6%
Alvo médio
$7.15
+772,0%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.00%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.19 | $-0.18 | -0.01% |
| 31 de Março de 2026 | $-0.19 | $-0.17 | -0.02% |
| 31 de Dezembro de 2025 | $-0.23 | $-0.42 | 0.19% |
| 30 de Setembro de 2025 | $-0.39 | $-0.26 | -0.13% |
| 30 de Junho de 2025 | $-0.33 | $-0.36 | 0.03% |
| 31 de Março de 2025 | $-0.34 | $-0.33 | -0.01% |
| 31 de Dezembro de 2024 | $-0.43 | $-0.35 | -0.08% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| LGVN | — | -0.4 | -49.9% | -1893.6% | -247.7% | 67.0% |
| ATOS | $5M | -0.1 | — | — | -71.7% | — |
| ABVC | $53M | -5.5 | 234.3% | — | -128.2% | — |
| ACTU | $142M | -5.8 | — | — | -843.5% | — |
| JSPR | — | -0.5 | — | — | — | — |
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| CLRB | — | -0.4 | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Cost of Revenue | $396.0K | $508.0K | $488.0K | $725.0K | $716.0K | $4M | |
| Gross Profit | $803.0K | $2M | $221.0K | $497.0K | $590.0K | $2M | |
| R&D Expense | $12M | $8M | $9M | $9M | $7M | $3M | |
| SG&A Expense | $12M | $10M | $12M | $8M | $10M | $3M | |
| Operating Expenses | $24M | $18M | $21M | $19M | $18M | $6M | |
| Operating Income | $-23M | $-17M | $-21M | $-18M | $-17M | $-4M | |
| Interest Expense | · | · | · | $1M | · | · | |
| Other Non-op | $680.0K | $549.0K | $-377.0K | $300.0K | $411.0K | $57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| EPS (Basic) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| EPS (Diluted) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| Shares (Basic) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| Shares (Diluted) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| EBITDA | $-22M | $-16M | · | $-18M | $-17M | · |
Balanço Patrimonial 25
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $19M | $5M | $11M | $26M | $816.0K | |
| Short-term Investments | · | $0 | $412.0K | $9M | $9M | · | |
| Receivables | $104.0K | $84.0K | $111.0K | $218.0K | $55.0K | · | |
| Prepaid Expense | $686.0K | $308.0K | $376.0K | $404.0K | $282.0K | $52.0K | |
| Current Assets | $5M | $20M | $6M | $20M | $35M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $4M | |
| PP&E (Gross) | $8M | $8M | $7M | $7M | $6M | $6M | |
| Accum. Depreciation | $6M | · | · | · | $3M | $3M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $176.0K | $202.0K | $193.0K | $244.0K | · | · | |
| Total Assets | $10M | $26M | $12M | $27M | $43M | $9M | |
| Accounts Payable | $423.0K | $99.0K | $638.0K | $2M | $645.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $2M | $650.0K | $1M | $2M | |
| Current Liabilities | $4M | $3M | $4M | $5M | $3M | $4M | |
| Capital Leases | $169.0K | $824.0K | $1M | $2M | · | · | |
| Other Non-current Liabilities | $330.0K | $265.0K | $0 | · | · | · | |
| Total Liabilities | $5M | $4M | $5M | $7M | $5M | $7M | |
| Long-term Debt | · | · | · | · | · | $311.0K | |
| Common Stock | · | · | · | $6.0K | $5.0K | · | |
| Paid-in Capital | $138M | $131M | $92M | $84M | $81M | · | |
| Retained Earnings | $-132M | $-110M | $-85M | $-63M | $-44M | · | |
| Treasury Stock | · | · | · | $100.0K | $100.0K | · | |
| AOCI | · | · | $0 | $-357.0K | · | · | |
| Stockholders' Equity | $6M | $22M | $7M | $21M | $37M | $2M | |
| Liabilities + Equity | $10M | $26M | $12M | $27M | $43M | $9M |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $700.0K | $700.0K | $700.0K | $1 | $1 | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $44.0K | |
| Amort. of Intangibles | $400.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | |
| Other Non-cash | $2M | $-923.0K | · | $5M | $6M | · | |
| Operating Cash Flow | $-19M | $-14M | $-19M | $-14M | $-10M | $-2M | |
| CapEx | $245.0K | $655.0K | $301.0K | $569.0K | $330.0K | $131.0K | |
| Investing Cash Flow | $-595.0K | $-640.0K | $8M | $-677.0K | $-11M | $-261.0K | |
| Stock Issued | $5M | $13M | $5M | $2.0K | $27M | · | |
| Net Stock Activity | $5M | $13M | · | · | $27M | · | |
| Financing Cash Flow | $5M | $29M | $5M | $-509.0K | $45M | $2M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-19M | $-15M | · | $-15M | $-10M | · |
Lucratividade 6
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 78.8% | · | 40.7% | 45.2% | · | |
| Operating Margin | -1942.2% | -690.7% | · | -1476.5% | -1336.6% | · | |
| Net Margin | -1893.6% | -667.8% | · | -1541.3% | -1305.1% | · | |
| EBITDA Margin | -1875.5% | -661.4% | · | -1476.5% | -1336.6% | · | |
| ROA | -126.8% | -84.9% | · | -53.7% | -65.5% | · | |
| ROE | -247.7% | -67.2% | · | -83.5% | -57.0% | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 7.6 | · | 4.2 | 13.1 | · | |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 | · | |
| Interest Coverage | · | · | · | -12.9 | · | · |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.0 | 0.1 | · | |
| Receivables Turnover | 12.8 | 24.5 | · | 9.0 | · | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -49.9% | 237.4% | -42.0% | -6.4% | -76.8% | · | |
| Revenue CAGR 3Y | -0.63% | 22.4% | -49.9% | · | · | · | |
| Revenue CAGR 5Y | -26.6% | · | · | · | · | · |
Avaliação (TTM) 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Net Income TTM | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| P/E | -0.4 | -0.7 | -1.3 | -35.8 | -134.1 | · | |
| Earnings Yield | -254.9% | -151.4% | -75.1% | -2.8% | -0.75% | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $287.0K | $398.0K | $365.0K | $137.0K | $316.0K | $381.0K | $603.0K | $773.0K | $468.0K | $548.0K | $63.0K | $150.0K | $217.0K | $279.0K | $121.0K | $265.0K | |
| Cost of Revenue | $105.0K | $134.0K | $108.0K | $12.0K | $170.0K | $106.0K | $74.0K | $91.0K | $124.0K | $219.0K | $65.0K | $96.0K | $124.0K | $203.0K | $41.0K | $173.0K | |
| Gross Profit | $182.0K | $264.0K | $257.0K | $125.0K | $146.0K | $275.0K | $529.0K | $682.0K | $344.0K | $329.0K | $-2.0K | $54.0K | $93.0K | $76.0K | $80.0K | $92.0K | |
| R&D Expense | $3M | $2M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $6M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $5M | $5M | $6M | $5M | $5M | $5M | |
| Operating Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | $-5M | $-5M | |
| Other Non-op | $98.0K | $39.0K | $52.0K | $89.0K | $369.0K | $170.0K | $200.0K | $230.0K | $87.0K | $32.0K | $-581.0K | $55.0K | $80.0K | $69.0K | $2M | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-4M | $-3M | $-4M | $-6M | $-5M | $-6M | $-5M | $-4M | $-5M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| EPS (Diluted) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| Shares (Basic) | 31,377,630 | 24,786,282,000 | -30,760,453,000 | 18,373,198,000 | 15,013,072 | 14,950,734,000 | -13,240,097,000 | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | 51,399,094 | 2,117,877,000 | 2,110,544 | 2,103,362 | -41,887,681 | 21,001,613 | |
| Shares (Diluted) | 31,377,630 | 24,786,282,000 | -30,760,453,000 | 18,373,198,000 | 15,013,072 | 14,950,734,000 | -13,240,097,000 | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | 51,399,094 | 2,117,877,000 | 2,110,544 | 2,103,362 | -41,887,681 | 21,001,613 | |
| EBITDA | $-6M | $-5M | · | $-7M | $-5M | $-5M | · | $-5M | $-3M | $-4M | · | $-5M | $-6M | $-5M | · | $-5M |
Balanço Patrimonial 24
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $5M | $9M | $10M | $14M | $19M | $23M | $12M | $2M | $5M | $2M | $3M | $5M | $11M | $14M | |
| Short-term Investments | · | · | · | · | · | $0 | · | $0 | · | $351.0K | $412.0K | $2M | · | · | $9M | $9M | |
| Receivables | $65.0K | $68.0K | $104.0K | $52.0K | $31.0K | $29.0K | $84.0K | $380.0K | $218.0K | $178.0K | $111.0K | $96.0K | $96.0K | $96.0K | $218.0K | · | |
| Prepaid Expense | $1M | $1M | $686.0K | $1M | $904.0K | $919.0K | $308.0K | $609.0K | $817.0K | $1M | $376.0K | $1M | $2M | $1M | $404.0K | $744.0K | |
| Current Assets | $11M | $17M | $5M | $10M | $11M | $15M | $20M | $24M | $13M | $4M | $6M | $5M | $10M | $15M | $20M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $12.0K | $18.0K | $176.0K | $178.0K | $200.0K | $201.0K | $202.0K | $203.0K | $204.0K | $190.0K | $193.0K | · | · | · | $244.0K | · | |
| Total Assets | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M | |
| Accounts Payable | $633.0K | $293.0K | $423.0K | $1M | $700.0K | $367.0K | $99.0K | $887.0K | $600.0K | $1M | $638.0K | $829.0K | $2M | · | $2M | $527.0K | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $613.0K | $650.0K | $728.0K | |
| Current Liabilities | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $4M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $60.0K | $169.0K | $336.0K | $501.0K | $664.0K | $824.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | · | $2M | · | |
| Other Non-current Liabilities | $0 | $0 | $330.0K | $315.0K | $308.0K | $302.0K | $265.0K | $199.0K | $132.0K | $66.0K | $0 | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $5M | $6M | $5M | $7M | $6M | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $153M | $153M | $138M | $137M | $132M | $132M | $131M | $131M | $116M | $92M | $92M | $86M | $85M | $84M | $84M | $83M | |
| Retained Earnings | $-143M | $-137M | $-132M | $-127M | $-120M | $-115M | $-110M | $-106M | $-101M | $-89M | $-85M | $-79M | $-73M | $-67M | $-63M | $-58M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| AOCI | · | · | · | · | · | · | · | $-1.0K | $-1.0K | $1.0K | · | $-309.0K | $-335.0K | $-299.0K | $-357.0K | · | |
| Stockholders' Equity | $10M | $16M | $6M | $10M | $13M | $17M | $22M | $26M | $15M | $3M | $7M | $7M | $11M | $16M | $21M | $25M | |
| Liabilities + Equity | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M |
Fluxo de Caixa 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Stock-based Comp | $373.0K | $379.0K | $376.0K | $448.0K | $513.0K | $340.0K | $390.0K | $1M | $230.0K | $295.0K | $413.0K | $499.0K | $699.0K | $421.0K | $476.0K | · | |
| Amort. of Intangibles | $0 | $100.0K | $0 | $100.0K | $100.0K | $200.0K | $-300.0K | $100.0K | $300.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| Other Non-cash | · | $-213.0K | · | · | · | $-226.0K | · | · | · | $477.0K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-5M | $-3M | $-4M | $-5M | $-5M | $-6M | $-2M | $-4M | |
| CapEx | $103.0K | $0 | $0 | $57.0K | $161.0K | $27.0K | $13.0K | $430.0K | $196.0K | $16.0K | $164.0K | $3.0K | $92.0K | $42.0K | $66.0K | $378.0K | |
| Investing Cash Flow | $-103.0K | $-20.0K | $-64.0K | $-118.0K | $-263.0K | $-150.0K | $-123.0K | $-478.0K | $-53.0K | $14.0K | $2M | $4M | $2M | $346.0K | $-570.0K | $-2M | |
| Stock Issued | · | · | $836.0K | · | · | · | $0 | $8M | $5M | $100.0K | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $75.0K | $15M | $777.0K | $4M | $-133.0K | $-58.0K | $-50.0K | $14M | $15M | $63.0K | $5M | $-50.0K | $-86.0K | $-17.0K | $-193.0K | $-27.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Lucratividade 6
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 66.3% | · | 91.2% | 46.2% | 72.2% | · | 88.2% | 73.5% | 60.0% | · | 36.0% | 42.9% | 27.2% | · | 34.7% | |
| Operating Margin | -2150.2% | -1199.8% | · | -5335.8% | -1707.9% | -1359.8% | · | -601.4% | -747.9% | -746.4% | · | -3440.7% | -2632.3% | -1690.3% | · | -1957.4% | |
| Net Margin | -2116.0% | -1190.0% | · | -5270.8% | -1591.1% | -1315.2% | · | -571.7% | -729.3% | -740.5% | · | -3404.0% | -2595.4% | -1665.6% | · | -1978.9% | |
| EBITDA Margin | -2080.5% | -1149.5% | · | -5189.8% | -1644.6% | -1307.3% | · | -601.4% | -705.1% | -709.8% | · | -3307.3% | -2540.1% | -1618.6% | · | -1881.9% | |
| ROA | -37.7% | -22.5% | · | -31.8% | -27.8% | -32.8% | · | -21.3% | -18.7% | -25.8% | · | -24.2% | -21.5% | -15.2% | · | -18.2% | |
| ROE | -52.7% | -28.5% | · | -40.6% | -36.5% | -49.6% | · | -27.4% | -26.1% | -41.9% | · | -32.7% | -27.7% | -18.4% | · | -22.3% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.9 | · | 2.1 | 3.4 | 5.6 | · | 7.7 | 4.2 | 0.7 | · | 1.5 | 2.5 | 4.1 | · | 6.3 | |
| Quick Ratio | 2.4 | 3.6 | · | 1.9 | 3.2 | 5.3 | · | 7.5 | 3.9 | 0.5 | · | 1.2 | 0.7 | 1.4 | · | 6.0 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 6.0 | 8.2 | · | 0.6 | 2.5 | 3.7 | · | 3.2 | 3.0 | 4.0 | · | 3.1 | 4.5 | 5.8 | · | · |
Avaliação (TTM) 4
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $911.0K | $1M | $1M | · | $1M | |
| Net Income TTM | $-23M | $-22M | · | $-22M | $-18M | $-17M | · | $-17M | $-18M | $-19M | · | $-21M | $-21M | $-19M | · | $-19M | |
| P/E | -0.6 | -0.8 | · | -0.5 | -0.5 | -0.4 | · | -0.3 | -0.2 | -0.4 | · | -3.0 | -6.3 | -9.2 | · | -39.4 | |
| Earnings Yield | -156.5% | -120.2% | · | -186.7% | -218.5% | -265.8% | · | -338.7% | -552.8% | -285.5% | · | -33.9% | -16.0% | -10.9% | · | -2.5% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $1M | $2M | $709.0K | $1M | $1M |
| Margem Bruta % | 67.0% | 78.8% | — | 40.7% | 45.2% |
| Margem Operacional % | -1942.2% | -690.7% | — | -1476.5% | -1336.6% |
| Lucro líquido | $-23M | $-16M | $-21M | $-19M | $-17M |
| EPS Diluído | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.3 | 7.6 | — | 4.2 | 13.1 |
| Índice de Liquidez Seca | 1.2 | 7.5 | — | 2.2 | 13.0 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-19M | $-15M | — | $-15M | $-10M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 41 declarantes · $3.3M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 15 (+6 vs trimestre anterior) | 5 (-4 vs trimestre anterior) | 4 (0 vs trimestre anterior) | 4 (+2 vs trimestre anterior) | +3.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $951.778 | 1.353.881 | 28,85% | Ações |
| Logos Global Management LP | $904.761 | 1.287.000 | 27,42% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $408.657 | 581.305 | 12,39% | Ações |
| BlackRock, Inc. | $157.592 | 224.170 | 4,78% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $126.528 | 179.982 | 3,83% | Ações |
| Beacon Pointe Advisors, LLC | $104.000 | 100.000 | 3,15% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $98.509 | 140.127 | 2,99% | Ações |
| JANE STREET GROUP, LLC | $90.369 | 128.547 | 2,74% | Ações |
| Mariner, LLC | $88.578 | 126.000 | 2,68% | Ações |
| ADAR1 Capital Management, LLC | $76.209 | 108.406 | 2,31% | Ações |
| TWO SIGMA SECURITIES, LLC | $39.349 | 55.973 | 1,19% | Ações |
| STATE STREET CORP | $31.902 | 45.380 | 0,97% | Ações |
| NORTHERN TRUST CORP | $30.439 | 43.299 | 0,92% | Ações |
| SCOTIA CAPITAL INC. | $21.090 | 30.000 | 0,64% | Ações |
| VANGUARD GROUP INC | $19.590 | 38.715 | 0,59% | Ações |
| Capital Investment Advisory Services, LLC | $18.647 | 26.525 | 0,57% | Ações |
| COMMONWEALTH EQUITY SERVICES, LLC | $17.680 | 25.155 | 0,54% | Ações |
| Hamilton Point Investment Advisors, LLC | $15.780 | 22.446 | 0,48% | Ações |
| MONETA GROUP INVESTMENT ADVISORS LLC | $14.974 | 21.300 | 0,45% | Ações |
| XTX Topco Ltd | $14.452 | 20.558 | 0,44% | Ações |
| ANCHYRA PARTNERS LLC | $14.060 | 20.000 | 0,43% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $13.938 | 19.827 | 0,42% | Ações |
| Accelerate Investment Advisors LLC | $10.018 | 14.250 | 0,30% | Ações |
| Valeo Financial Advisors, LLC | $7.640 | 10.867 | 0,23% | Ações |
| Cambridge Financial Group, LLC | $7.382 | 10.500 | 0,22% | Ações |
| Tower Research Capital LLC (TRC) | $5.922 | 8.424 | 0,18% | Ações |
| MCGUIRE CAPITAL ADVISORS INC | $2.812 | 4.000 | 0,09% | Ações |
| Steward Partners Investment Advisory, LLC | $1.673 | 2.380 | 0,05% | Ações |
| OSAIC HOLDINGS, INC. | $1.400 | 2.000 | 0,04% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $930 | 1.300 | 0,03% | Ações |
| Cornerstone Planning Group LLC | $705 | 1.125 | 0,02% | Ações |
| WELLS FARGO & COMPANY/MN | $703 | 1.000 | 0,02% | Ações |
| BARCLAYS PLC | $587 | 835 | 0,02% | Ações |
| MORGAN STANLEY | $478 | 680 | 0,01% | Ações |
| Allworth Financial LP | $92 | 130 | 0,00% | Ações |
| Aventura Private Wealth, LLC | $55 | 78 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $42 | 60 | 0,00% | Ações |
| Virtu Financial LLC | $41 | 58.583 | 0,00% | Ações |
| UBS Group AG | $4 | 5 | 0,00% | Ações |
| CWM, LLC | $3 | 3 | 0,00% | Ações |
| HUNTINGTON NATIONAL BANK | $2 | 1 | 0,00% | Ações |
Executivos da empresa 26 insiders · 11 diretores · 15 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Stephen H Willard | Chief Executive Officer | 1 de Julho de 2026 F | 771.681 | 0 | 0 | $0 |
| James Nathaniel Powell | Chief Executive Officer | 2 de Janeiro de 2026 F | 125.593 | 0 | 0 | $0 |
| Mohamed Wa'El Ahmed Hashad | Chief Executive Officer | 15 de Julho de 2025 A | 420.904 | 0 | 0 | $0 |
| Geoff Green | CEO | 4 de Abril de 2022 F | 133.904 | 0 | 0 | $0 |
| Lisa Locklear | Chief Financial Officer | 1 de Julho de 2026 F | 443.181 | 0 | 0 | $0 |
| James Clavijo | CFO and Treasurer | 29 de Junho de 2023 S | 47.303 | 0 | 0 | $0 |
| Joshua Hare | Chief Scientific Officer | 6 de Julho de 2026 A | 1.321.796 | 0 | 0 | $0 |
| Devin Blass | CTO & SVP of CMC | 1 de Julho de 2026 F | 425.735 | 0 | 0 | $0 |
| Nataliya Agafonova | Chief Medical Officer | 1 de Julho de 2026 F | 430.914 | 0 | 0 | $0 |
| Paul T Lehr | General Counsel, Secretary | 1 de Julho de 2026 F | 575.423 | 0 | 0 | $0 |
| Kwan-Hong Christopher Min | Chief Medical Officer | 4 de Abril de 2022 A | 151.978 | 0 | 0 | $0 |
| George A. Paletta Jr. | Conselheiro | 1 de Outubro de 2025 A | 34.000 | 0 | 0 | $0 |
| Khoso Baluch | Conselheiro | 11 de Agosto de 2025 P | 52.516 | 0 | 0 | $0 |
| Roger Joseph Hajjar | Conselheiro | 15 de Julho de 2025 A | 33.000 | 0 | 0 | $0 |
| Neha J. Motwani | Conselheiro | 15 de Julho de 2025 A | 33.000 | 0 | 0 | $0 |
| Ursula Ungaro | Conselheiro | 15 de Julho de 2025 A | 41.000 | 0 | 0 | $0 |
| Rock Soffer | Conselheiro | 15 de Julho de 2025 A | 226.034 | 0 | 0 | $0 |
| Richard N Kender | Conselheiro | 15 de Julho de 2025 A | 33.000 | 0 | 0 | $0 |
| Neil E Hare | Conselheiro | 15 de Agosto de 2024 A | 29.352 | 0 | 0 | $0 |
| Cathy Ross | Conselheiro | 10 de Janeiro de 2024 P | 10.000 | 0 | 0 | $0 |
| Jeffrey Pfeffer | Conselheiro | 28 de Dezembro de 2023 P | 15.000 | 0 | 0 | $0 |
| Douglas W Losordo | Conselheiro | 21 de Dezembro de 2023 A | 5.000 | 0 | 0 | $0 |
| Todd C Girolamo | Conselheiro | 21 de Dezembro de 2022 A | 5.000 | 0 | 0 | $0 |
| Donald M Soffer | Conselheiro | 21 de Dezembro de 2022 A | 6.693.737 | 0 | 0 | $0 |
| Erin Borger | Conselheiro | 21 de Dezembro de 2022 A | 0 | 0 | 0 | $0 |
| DS MED LLC | Detentor de 10% | 17 de Maio de 2022 J | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Joshua M. Hare, M.D. (2) ×4 declarações | 15 de Abril de 2024 | — | Declaração inicial | — | SEC |
| DS MED LLC (2), Donald M. Soffer (2) ×2 declarações | 25 de Maio de 2022 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.